Swiss National Bank Boosts Stock Position in Change Healthcare Inc. (NASDAQ:CHNG)
Swiss National Bank Boosts Stock Position in Change Healthcare Inc. (NASDAQ:CHNG)
Swiss National Bank raised its position in shares of Change Healthcare Inc. (NASDAQ:CHNG – Get Rating) by 7.7% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 552,451 shares of the company's stock after purchasing an additional 39,700 shares during the quarter. Swiss National Bank owned 0.18% of Change Healthcare worth $12,043,000 at the end of the most recent reporting period.
Change Healthcare Inc.(纳斯达克代码：Chng-Get Rating)在最近一次提交给美国证券交易委员会的13F文件中称，瑞士央行第一季度将其在该公司股票的持仓量上调了7.7%。该基金在本季度额外购买了39,700股后，持有552,451股该公司股票。在最近一个报告期结束时，瑞士国家银行拥有Change Healthcare 0.18%的股份，价值12,043,000美元。
A number of other hedge funds have also recently modified their holdings of CHNG. C M Bidwell & Associates Ltd. purchased a new stake in shares of Change Healthcare in the first quarter worth about $90,000. FNY Investment Advisers LLC boosted its stake in shares of Change Healthcare by 5,400.0% in the first quarter. FNY Investment Advisers LLC now owns 5,500 shares of the company's stock worth $119,000 after buying an additional 5,400 shares during the last quarter. Advisor Group Holdings Inc. boosted its stake in shares of Change Healthcare by 13.0% in the fourth quarter. Advisor Group Holdings Inc. now owns 6,335 shares of the company's stock worth $135,000 after buying an additional 731 shares during the last quarter. Fieldpoint Private Securities LLC boosted its stake in shares of Change Healthcare by 27.8% in the first quarter. Fieldpoint Private Securities LLC now owns 6,579 shares of the company's stock worth $143,000 after buying an additional 1,433 shares during the last quarter. Finally, Comerica Bank boosted its stake in shares of Change Healthcare by 40.0% in the first quarter. Comerica Bank now owns 14,658 shares of the company's stock worth $346,000 after buying an additional 4,188 shares during the last quarter. Hedge funds and other institutional investors own 96.09% of the company's stock.
其他一些对冲基金最近也调整了对Chng的持股。C M Bidwell&Associates Ltd.在第一季度购买了Change Healthcare价值约90,000美元的新股。FNY Investment Advisers LLC在第一季度将其在Change Healthcare的股份增加了5,400.0%。FNY Investment Advisers LLC现在持有该公司5,500股股票，价值11.9万美元，在上个季度又购买了5,400股。Advisor Group Holdings Inc.在第四季度增持了Change Healthcare股票13.0%。Advisor Group Holdings Inc.现在持有该公司6,335股股票，价值135,000美元，上个季度又购买了731股。FieldPoint Private Securities LLC在第一季度将其在Change Healthcare的持股增加了27.8%。FieldPoint Private Securities LLC现在持有该公司6,579股股票，价值143,000美元，上个季度又购买了1,433股。最后，Comerica Bank在第一季度增持了Change Healthcare股票40.0%。Comerica Bank现在持有14,658股该公司股票，价值34.6万美元，上个季度又购买了4,188股。对冲基金和其他机构投资者持有该公司96.09%的股票。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
A number of analysts have recently commented on the company. Piper Sandler restated a "buy" rating and issued a $26.00 target price on shares of Change Healthcare in a research note on Tuesday, April 26th. William Blair reaffirmed a "market perform" rating on shares of Change Healthcare in a report on Friday, June 3rd. Cowen set a $27.75 price target on Change Healthcare in a report on Monday, June 20th. Credit Suisse Group upped their price target on Change Healthcare from $25.75 to $27.75 and gave the stock a "neutral" rating in a report on Tuesday, May 31st. Finally, SVB Leerink reaffirmed an "outperform" rating on shares of Change Healthcare in a report on Thursday, May 26th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, Change Healthcare has an average rating of "Moderate Buy" and an average price target of $27.00.
一些分析师最近对该公司发表了评论。派珀·桑德勒在4月26日(星期二)的一份研究报告中重申了对Change Healthcare的“买入”评级，并为其股票设定了26.00美元的目标价。威廉·布莱尔在6月3日星期五的一份报告中重申了对Change Healthcare股票的“市场表现”评级。考恩在6月20日星期一的一份报告中为Change Healthcare设定了27.75美元的目标价。瑞士信贷集团将其对Change Healthcare的目标价从25.75美元上调至27.75美元，并在5月31日周二的一份报告中给予该股“中性”评级。最后，SVB Leerink在5月26日(星期四)的一份报告中重申了对Change Healthcare股票的“跑赢大盘”评级。两名研究分析师对该股的评级为持有，四名分析师对该股的评级为买入。根据MarketBeat的数据，Change Healthcare的平均评级为“中等买入”，平均目标价为27.00美元。
Change Healthcare Price Performance
改变医疗价格表现
Change Healthcare (NASDAQ:CHNG – Get Rating) last announced its earnings results on Wednesday, May 25th. The company reported $0.34 EPS for the quarter, missing analysts' consensus estimates of $0.37 by ($0.03). Change Healthcare had a negative net margin of 2.20% and a positive return on equity of 12.02%. The firm had revenue of $920.13 million for the quarter, compared to analyst estimates of $902.86 million. During the same period in the previous year, the company earned $0.36 EPS. Change Healthcare's revenue was up 7.6% compared to the same quarter last year. As a group, analysts predict that Change Healthcare Inc. will post 1.3 EPS for the current fiscal year.
Change Healthcare(纳斯达克：Chng-Get Rating)最近一次公布财报是在5月25日星期三。该公司公布本季度每股收益为0.34美元，低于分析师普遍预期的0.37美元(0.03美元)。Change Healthcare的净利润率为负2.20%，股本回报率为正12.02%。该公司本季度营收为9.2013亿美元，而分析师预期为9.0286亿美元。去年同期，该公司每股收益为0.36美元。与去年同期相比，Change Healthcare的收入增长了7.6%。分析师预计，作为一个整体，Change Healthcare Inc.将公布本财年每股收益1.3%。
Change Healthcare Profile
更改医疗保健配置文件
(Get Rating)
(获取评级)
Change Healthcare Inc, an independent healthcare technology company, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system. It operates through three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services.
Change Healthcare Inc.是一家独立的医疗技术公司，提供数据和分析驱动的解决方案，以增强美国医疗系统的临床、财务、行政和患者参与成果。它通过三个部门运作：软件和分析、网络解决方案和技术支持的服务。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Change Healthcare (CHNG)
- Which Semiconductor Stocks Are Ready For Big Price Moves?
- Miners Advance On Earnings Despite Broader Economic Challenges
- Lowe's Stands Out Amid Q2 Retail Reports
- Agilent Technologies Proves Its Worth VS Illumina
- Target's Results Cap Upside Potential For Retail Stocks
- 免费获取StockNews.com关于Change Healthcare(CHNG)的研究报告
- 哪些半导体类股准备好迎接价格大幅波动？
- 尽管面临更广泛的经济挑战，矿商的收益仍在上涨
- Lowe‘s在第二季度零售报告中脱颖而出
- 安捷伦科技对Illumina证明了自己的价值
- 塔吉特的业绩上限零售类股的上行潜力
Receive News & Ratings for Change Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Change Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
接受《改变医疗保健日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收最新新闻和分析师对Change Healthcare及相关公司的评级的每日摘要。
译文内容由第三方软件翻译。